Discussion of establishment of acceptance criteria in drug specificationMA Li, YANG Hua-xin, TAN De-jiang, HANG Tai-jun523-527
Progress in quality control of implantationsLIN Xiao-ming, GUO Ning-zi, YANG Hua-xin, LIU Yang, LIU Wan-hui528-535
Study on the dissolution characteristics of domestic cefradine granules in vitro and its influence on pharmacokinetics in vivo using physiologically based pharmacokinetics model predictionZHANG Dou-sheng, WANG Chen, YAO Shang-chen, HU Chang-qin536-540
Simultaneous determination of compound preparation of ceftazidime-acibactam for injection by HPLC-DADWANG Yan, YAO Shang-chen, ZHANG Pei-pei, ZOU Wen-bo, LI Jin, XU Ming-zhe, HU Chang-qin541-546
Establishment of national reference standard of isepamicin sulfateTIAN Ye, FENG Yan-chun, LIU Ying, YAO Shang-chen, HU Chang-qin547-550
Research progress in quality control and evaluation of transdermal patchesMA Xun, ZUO Ning, CHEN Hua, LI You-xin551-557
Alternative research on bioassays of synthetic oxytocinZHANG Yuan, LI Zhen, TAN De-jiang, WU Yan-lin, TANG Li-ming, LU Yi-hong, YU De-zhi, LIN Lan, GAO Hua558-564
Establishment of the quality analysis method for sodium acetate [11C] injectionJIA Juan-juan, ZHAI Shi-zhen, SHI Ya-qin, YAO Jing, GONG Quan-sheng, ZHANG Wen-zai565-570
Development of a standardized method for in vitro release analysis of doxorubicin hydrochloride liposome injectionSUN Jia-bei, OU Ting, WANG Zhuo, GAO Yu-cheng, SHI Ya-qin571-576